FDA Inspection 1204620 — Amy Lightner MD

Amy Lightner MD — FEI 3026147808

The FDA completed an inspection of Amy Lightner MD on April 26, 2023 in Cleveland, OH. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 26, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Cleveland, OH (United States)

Additional Details

Sponsor-Investigator (S-I)

Citations

IDCFRDescription
2272721 CFR 312.64(b)Safety Reports - Serious Events
2272821 CFR 312.64(b)Safety Reports - Non-Serious Events
748221 CFR 312.50General responsibilities of sponsors
753021 CFR 312.62(b)Case history records- inadequate or inadequate
755821 CFR 312.57(c)Record retention requirement
756021 CFR 312.60FD-1572, protocol compliance